The outlook of companies tied to flagship drugs like Viagra presents a nuanced investment landscape . While the initial boom of copyright, fueled by Viagra's extraordinary popularity, generated substantial wealth , the loss of exclusivity in key regions has introduced considerable uncertainty . Investors are now assessing the effect of rival medica